age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
72.59698
|
male
| 0
| 46
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 8
|
$25-$50k
| 9
| 114,631
| null | null | 21.5
|
white
| 37
| 103
| 0.181
| 0.092987
| 18
| 1
| 0
|
yes
| 0.8
| 0.5
|
no dnr
| 46
| 128
| 10.798828
| 115
| 12
| 36.89844
| 292.5
| 3.199707
| 1.699951
| 0.599976
| 146
| 7.40918
| 279
| 24
| 4,000
| 0
| 1
|
adl>=4 (>=5 if sur)
| 1
| 136
| 1
|
70.125
|
female
| 0
| 22
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 13
|
under $11k
| 9
| 89,992
| null | null | 40.666657
|
black
| 32.796875
| 63
| 0.305969
| 0.19397
| 2
| 1
| 0
|
metastatic
| 0.7
| 0.4
|
no dnr
| 22
| 62
| 13.898438
| 70
| 32
| 36.39844
| 155
| null | null | 0.699951
| 132
| 7.449219
| 85
| 19
| 2,980
| null | 0
|
no(M2 and SIP pres)
| 0
| 366
| 1
|
46.612
|
female
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 139,684
| null | null | 31
|
white
| 29.796875
| 62
| 0.606934
| 0.500977
| 7
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 38
| 105
| 3.599609
| 100
| 24
| 37.5
| null | null | 0.299988
| 1
| 143
| null | 93
| 11
| 2,400
| null | 0
| null | 0
| 140
| 1
|
42.56799
|
female
| 0
| 47
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 15
|
$11-$25k
| 0
| 90,541
| 54,508.6875
| 51,188
| 16.25
|
black
| 25.199219
| 40
| 0.703979
| 0.61499
| 1
| 0
| 0
|
yes
| 1
| 1
|
no dnr
| 47
| 63
| 4.899414
| 105
| 24
| 35.89844
| null | null | 3.699707
| 1.199951
| 137
| null | 113
| 34
| null | 0
| 0
|
<2 mo. follow-up
| 0
| 53
| 1
|
41.60699
|
male
| 0
| 32
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 37
| null | null | null | 20.5
|
white
| 36.09375
| 88
| 0.333984
| 0.218994
| 16
| 0
| 0
|
yes
| 0.75
| 0.75
|
no dnr
| 32
| 73
| 8.099609
| 114
| 28
| 36.5
| 291.375
| 3.899902
| 0.599976
| 0.5
| 139
| 7.319336
| 80
| 9
| 2,050
| null | 2
|
no(M2 and SIP pres)
| 2
| 587
| 0
|
48.71698
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
under $11k
| 0
| 64,982
| 36,829.125
| 34,040
| 46
|
black
| 48.59375
| 54
| 0.269958
| 0.162994
| 3
| 0
| 0
|
no
| 0.4
| 0.2
|
dnr after sadm
| 8
| 68
| 11.199219
| 65
| 10
| 35.29688
| 395.1875
| 2.099609
| 13.699219
| 6.899414
| 142
| 7.339844
| 231
| 120
| 160
| null | 1
|
<2 mo. follow-up
| 1
| 11
| 1
|
43.00598
|
male
| 0
| 12
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 9
|
$25-$50k
| 26
| 35,825
| 22,253.6562
| 24,001
| 17.5
|
white
| 36.59375
| 64
| 0.199982
| 0.106995
| 6
| 0
| 0
|
yes
| null | null |
no dnr
| 12
| 99
| 10.798828
| 72
| 20
| 37.39844
| null | 2.699707
| 0.399963
| 1.199951
| 128
| null | 102
| 17
| 6,150
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 147
| 1
|
82.52399
|
female
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 18
|
$25-$50k
| 44
| 35,284
| 21,131.6719
| 19,206
| 31.5
|
black
| 32.796875
| 38
| 0.314941
| 0.201996
| 1
| 0
| 1
|
no
| 0.4
| 0.3
|
no dnr
| 12
| 73
| 6.699219
| 76
| 20
| 36.09375
| null | 3.799805
| 1.299805
| 1.299805
| 136
| null | 86
| 16
| 2,300
| null | null |
<2 mo. follow-up
| 4.921875
| 12
| 1
|
44.57199
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 26
| 53,322
| 33,376.5625
| 33,202
| 27.333328
|
white
| 28.597656
| 36
| 0.737915
| 0.655884
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 14
| 63
| 16.699219
| 115
| 22
| 37.69531
| 157.125
| 1.899902
| 4.699219
| 0.399963
| 135
| 7.439453
| 100
| 13
| 2,675
| 5
| 1
|
SIP>=30
| 1
| 584
| 0
|
69.72998
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 51,703
| 29,591.9531
| 31,750
| 14.666664
|
white
| 24.199219
| 33
| 0.738892
| 0.657959
| 1
| 0
| 0
|
yes
| 0.95
| 0.93
|
no dnr
| 14
| 52
| 8
| 65
| 24
| 36.19531
| null | 3.699707
| 1
| 1
| 135
| null | 114
| 11
| 1,950
| null | null | null | 2.767578
| 584
| 0
|
53.72998
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| null | 2,964.75
| 2,813
| 13
|
black
| 14.798828
| 15
| 0.770996
| 0.524902
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 4
| 97
| 13.099609
| 106
| 32
| 36.59375
| 133.3125
| null | null | 1
| 135
| 7.289062
| 159
| 40
| 1,200
| null | null |
no(M2 and SIP pres)
| 1.962891
| 492
| 1
|
68.91699
|
female
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
|
$11-$25k
| 0
| 87,973
| 46,006.25
| 46,716
| 33
|
white
| 34.59375
| 59
| 0.471985
| 0.352966
| 14
| 0
| 0
|
no
| 0.25
| 0.5
|
dnr after sadm
| 7
| 123
| 1.5
| 185
| 26
| 38
| 280
| null | 2.5
| 1
| 141
| 7.459961
| 136
| 40
| 1,220
| null | null |
<2 mo. follow-up
| 3.089356
| 9
| 1
|
68.211
|
male
| 0
| 56
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 120,387
| 74,504.75
| 74,446
| 18.5
|
white
| 27.699219
| 30
| 0.736938
| 0.587891
| 1
| 1
| 0
|
no
| 0.8
| 0.8
|
dnr after sadm
| 41
| 70
| 13.699219
| 70
| 22
| 36.19531
| 153.3125
| null | null | 0.899902
| 140
| 7.439453
| 102
| 21
| null | null | null | null | 2.660156
| 72
| 1
|
78.79297
|
female
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 41
| 77,543
| 46,027.3438
| 46,290
| 14.5
|
black
| 29.097656
| 72
| 0.263977
| 0.15799
| 15
| 1
| 0
|
yes
| 0.2
| 0.1
|
dnr after sadm
| 2
| 70
| 3.099609
| 115
| 42
| 38.19531
| 157.5
| null | null | 3
| 133
| 7.5
| 115
| 66
| 680
| null | null |
<2 mo. follow-up
| 3.062012
| 7
| 1
|
58.86099
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 2
| 10
|
$25-$50k
| 0
| 6,491
| 3,419.3613
| 1,940
| 9
|
white
| 13.798828
| 19
| 0.778931
| 0.537964
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 4
| 105
| 2.199707
| 135
| 32
| 38.29688
| 280
| null | 1.5
| 4.799805
| 127
| 7.30957
| 446
| 102
| 282
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 223
| 1
|
61.19598
|
female
| 0
| 29
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 17
|
$25-$50k
| 0
| null | 39,673.9688
| 41,995
| 15.5
|
black
| 25.5
| 47
| 0.79895
| 0.73291
| 1
| 1
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 29
| 0
| 19.796875
| 0
| 0
| 38.39844
| 148
| 2.099609
| null | 0.5
| 128
| 7.399414
| 132
| 10
| 1,710
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 582
| 0
|
66.22296
|
male
| 0
| 41
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 41
| 85,318
| 52,149.25
| 65,274
| 30
|
black
| 18.398438
| 43
| 0.777954
| 0.705933
| 1
| 0
| 0
|
no
| 0.25
| 0.2
|
no dnr
| 41
| 58
| 16.296875
| 105
| 28
| 36
| 158
| 1.599854
| 5.699219
| 3.699707
| 130
| 7.349609
| 30
| 35
| 70
| null | null |
no(M2 and SIP pres)
| 2.446289
| 204
| 1
|
49.54999
|
female
| 0
| 15
|
Lung Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 11,291
| 8,300.6562
| 9,814
| 6.666664
|
white
| 13.398438
| 8
| 0.799927
| 0.575928
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 15
| 52
| 7.299805
| 81
| 24
| 36.59375
| null | null | 0.699951
| 0.899902
| 139
| null | 88
| 12
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 582
| 0
|
26.10799
|
female
| 1
| 19
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| null | 32,633.625
| 32,219
| 16
|
black
| 22.296875
| 50
| 0.650879
| 0.55188
| 10
| 0
| 0
|
metastatic
| 0.4
| 0.1
|
dnr after sadm
| 5
| 155
| 9.298828
| 50
| 26
| 35.5
| 409.5
| 3.099609
| null | 1.799805
| 147
| 7.459961
| 139
| 43
| 2,195
| null | null |
<2 mo. follow-up
| 2.739258
| 19
| 1
|
61.73898
|
male
| 1
| 8
|
Coma
|
Coma
| 0
| 16
|
$25-$50k
| 100
| 28,443
| 17,677.4062
| 17,837
| 26
|
white
| 21.5
| 27
| 0.30896
| 0.237976
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 5
| 49
| 41.296875
| 50
| 7
| 38.09375
| 106
| null | 24.796875
| 3.699707
| 135
| 7.399414
| 299
| 41
| 20
| null | 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
69.01599
|
female
| 1
| 21
|
Coma
|
Coma
| 2
| 4
|
under $11k
| 44
| null | 23,308.2031
| 24,254
| 19.666656
|
black
| 27
| 52
| 0.365967
| 0.292969
| 1
| 1
| 0
|
no
| 0
| 0
|
dnr after sadm
| 7
| 78
| 25.097656
| 155
| 32
| 38.5
| 203.3125
| 2.299805
| 0.5
| 5.599609
| 138
| 7.459961
| 310
| 91
| 0
| null | 1
|
<2 mo. follow-up
| 1
| 21
| 1
|
72.66797
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
under $11k
| 26
| null | 4,063.8418
| 3,017
| 12
|
white
| 34.5
| 31
| 0.435974
| 0.234985
| 1
| 1
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 2
| 127
| 18.097656
| 125
| 29
| 36
| 260
| 2
| 1.099854
| 0.799927
| 123
| 7.529297
| 364
| 36
| 1,462
| 7
| 7
|
adl>=4 (>=5 if sur)
| 7
| 177
| 1
|
67.461
|
female
| 0
| 22
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| null | 32,987.5625
| 29,834
| 24.333328
|
white
| 32.898438
| 26
| 0.469971
| 0.153992
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 22
| 79
| 10
| 74
| 20
| 36.5
| null | 4.099609
| 0.599976
| 1
| 143
| null | 112
| 9
| 4,550
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 579
| 0
|
76.96399
|
male
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 7
|
$11-$25k
| 9
| null | 25,542.1406
| 28,982
| 14
|
black
| 27.699219
| 44
| 0.589966
| 0.480957
| 1
| 1
| 0
|
yes
| null | null |
no dnr
| 20
| 73
| 4.5
| 80
| 24
| 36.19531
| null | 3.699707
| 0.599976
| 1
| 138
| null | 233
| 9
| 3,875
| 3
| 0
| null | 0
| 577
| 0
|
52.20499
|
female
| 0
| 36
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 7
|
under $11k
| 44
| 86,035
| 53,994.6562
| 61,818
| 25.75
|
black
| 26.398438
| 49
| 0.681885
| 0.588989
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 36
| 62
| 7.799805
| 70
| 16
| 36.79688
| null | 2.299805
| 1.399902
| 1.399902
| 135
| null | 90
| 17
| 1,800
| null | 0
| null | 0
| 577
| 0
|
67.94495
|
male
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 0
| 97,439
| 54,870.0625
| 59,514
| 32.25
|
white
| 19.199219
| 25
| 0.828979
| 0.770996
| 5
| 0
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 5
| 107
| 8.699219
| 80
| 20
| 37.5
| null | null | 0.399963
| 1
| 140
| null | 83
| 6
| 2,840
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 223
| 1
|
68.99695
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
| null | 0
| 94,104
| 52,377.1875
| 47,141
| 48
|
white
| 43.796875
| 79
| 0.192993
| 0.102997
| 22
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 4
| 98
| 6.399414
| 65
| 20
| 35.89844
| 304.75
| null | 0.699951
| 3.799805
| 139
| 7.419922
| 88
| 115
| 2,575
| null | null |
<2 mo. follow-up
| 2.287109
| 4
| 1
|
89.82098
|
female
| 0
| 19
|
Coma
|
Coma
| 1
| 12
|
under $11k
| 55
| null | null | null | 11.333328
|
black
| 15.298828
| 12
| 0.436951
| 0.363953
| 1
| 0
| 0
|
no
| 0.6
| 0.6
|
dnr after sadm
| 1
| 115
| 1.799805
| 75
| 29
| 35.39844
| 160
| 2.899902
| 0.899902
| 1.5
| 134
| 7.439453
| 110
| 43
| 5,860
| null | 1
|
adl>=4 (>=5 if sur)
| 1
| 577
| 0
|
63.159
|
male
| 1
| 17
|
Coma
|
Coma
| 0
| 7
|
under $11k
| 55
| null | 57,245.75
| 58,565
| 42.666657
|
black
| 31.097656
| 41
| 0.202972
| 0.141998
| 3
| 0
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 17
| 112
| 19
| 0
| 28
| 36.5
| 352.375
| 4.099609
| 0.399963
| 1.099854
| 138
| 7.429688
| 171
| 22
| 2,790
| null | 6
|
<2 mo. follow-up
| 6
| 17
| 1
|
72.81897
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| 20
|
>$50k
| 0
| 6,116
| 4,265.1016
| 4,535
| 5.5
|
white
| 25.898438
| 18
| 0.464966
| 0.149994
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
dnr after sadm
| 2
| 120
| 40
| 115
| 26
| 35.19531
| 360
| 1.899902
| 1
| 1.199951
| 137
| 7.389648
| 111
| 13
| 2,405
| 1
| 2
|
adl>=4 (>=5 if sur)
| 2
| 73
| 1
|
43.34598
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 14
|
>$50k
| 0
| 12,808
| 6,627.9453
| 4,023
| 12
|
white
| 14.199219
| 12
| 0.799927
| 0.575928
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 5
| 90
| 6.199219
| 64
| 20
| 36.59375
| 130
| null | null | 1.799805
| 138
| 7.389648
| 109
| 28
| 4,315
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 403
| 1
|
80.58295
|
male
| 1
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
| null | 0
| null | 21,836.2969
| 19,572
| 21
|
white
| 20.699219
| 27
| 0.697998
| 0.60791
| 1
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 3
| 125
| 13.599609
| 145
| 20
| 39.5
| 86.14062
| 3.099609
| 0.599976
| 1.799805
| 155
| 7.319336
| 210
| 46
| 2,920
| null | null |
<2 mo. follow-up
| 2.748535
| 14
| 1
|
42.24197
|
male
| 1
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 13
|
$25-$50k
| 0
| null | null | null | 40.666657
|
black
| 49.296875
| 83
| 0.312988
| 0.199982
| 2
| 0
| 0
|
no
| 0.3
| 0.25
|
dnr after sadm
| 16
| 63
| null | 70
| 32
| 37.89844
| 196.65625
| 2
| null | 0.799927
| 135
| 7.399414
| 103
| 8
| 4,150
| null | 0
|
<2 mo. follow-up
| 0
| 22
| 1
|
66.82794
|
female
| 0
| 115
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 445,984
| null | null | 41
|
white
| 31.398438
| 79
| 0.563965
| 0.451965
| 20
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 115
| 58
| 5.899414
| 60
| 22
| 36.09375
| 136.71875
| null | null | 1
| 138
| 7.349609
| 100
| 13
| 1,760
| null | null |
Coma or Intub
| 2.143555
| 244
| 1
|
70.69397
|
female
| 1
| 19
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
| null | 0
| null | null | null | 45.666657
|
white
| 27.097656
| 45
| 0.596924
| 0.488953
| 2
| 0
| 0
|
yes
| 0.9
| 0.8
|
dnr after sadm
| 10
| 78
| 12.199219
| 78
| 24
| 36.5
| null | null | 0.299988
| 1
| 141
| null | 112
| 24
| 1,150
| null | 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
65.71698
|
male
| 0
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 11
|
under $11k
| 9
| 6,897
| 4,673.8594
| 4,331
| 9
|
black
| 24.898438
| 41
| 0.622925
| 0.437988
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 30
| 10.398438
| 180
| 33
| 36.09375
| 350
| 2.599609
| 0.199982
| 0.599976
| 120
| 7.55957
| 224
| 4
| 7,360
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 575
| 0
|
64.07397
|
female
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 280,170
| 158,999.875
| 159,265
| 40.5
|
white
| 33.5
| 60
| 0.511963
| 0.394958
| 53
| 0
| 0
|
no
| 0.1
| 0.1
|
dnr after sadm
| 7
| 50
| 24.898438
| 115
| 27
| 35.79688
| 438.0625
| null | 0.5
| 5.199219
| 147
| 7.429688
| 272
| 41
| 705
| null | null |
<2 mo. follow-up
| 2.162598
| 9
| 1
|
74.20898
|
male
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 0
|
$11-$25k
| 0
| null | null | null | 54
|
white
| 42
| 70
| 0.211975
| 0.115997
| 19
| 0
| 0
|
no
| 0.2
| 0.2
|
no dnr
| 12
| 99
| 7.5
| 70
| 16
| 36.19531
| null | 3.599609
| 0.699951
| 1.199951
| 139
| null | 91
| 8
| 2,525
| null | null |
<2 mo. follow-up
| 2.253906
| 12
| 1
|
67.896
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
|
under $11k
| 100
| null | 13,553
| 15,362
| 24.5
|
white
| 27.199219
| 45
| 0.291992
| 0.181
| 1
| 1
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 9
| 113
| 9.699219
| 95
| 16
| 35.79688
| null | 4
| 0.599976
| 0.799927
| 138
| null | 92
| 7
| 6,600
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 92
| 1
|
61.77698
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 86,438
| 48,095.8125
| 53,617
| 28.333328
|
white
| 27.5
| 27
| 0.75
| 0.670898
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 16
| 110
| 22.699219
| 110
| 8
| 38.39844
| 185.6875
| null | 0.599976
| 1.099854
| 131
| 7.449219
| 164
| 14
| 2,700
| null | 0
|
no(M2 and SIP pres)
| 0
| 573
| 0
|
68.99896
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| 3
|
under $11k
| 0
| 7,860
| 5,247.0859
| 4,711
| 14
|
black
| 30.199219
| 29
| 0.681885
| 0.511963
| 1
| 1
| 0
|
no
| 0.6
| 0.4
|
no dnr
| 4
| 65
| 8.199219
| 65
| 23
| 37
| 138.75
| null | 5.599609
| 0.899902
| 139
| 7.489258
| 121
| 23
| 4,140
| 3
| 3
|
adl>=4 (>=5 if sur)
| 3
| 474
| 1
|
28.75299
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 9
| null | null | null | 14
|
white
| 26.796875
| 17
| 0.858887
| 0.809937
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 9
| 25
| 14.599609
| 0
| 12
| 37.39844
| 368
| 2.5
| 19.5
| 1.5
| 150
| 7.419922
| 85
| 25
| 2,305
| null | null | null | 3.20459
| 572
| 0
|
75.99695
|
male
| 1
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 8
|
$11-$25k
| 0
| null | 38,309.9688
| 35,311
| 46
|
white
| 29.398438
| 60
| 0.356995
| 0.23999
| 14
| 0
| 0
|
metastatic
| 0.05
| 0
|
dnr after sadm
| 1
| 82
| 24.699219
| 105
| 12
| 36
| null | null | 0.099991
| 1.299805
| 134
| null | 84
| 28
| 1,460
| null | 7
|
<2 mo. follow-up
| 7
| 10
| 1
|
47.80298
|
male
| 0
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 10
|
under $11k
| 0
| null | 2,903.2246
| 3,018
| 9
|
white
| 20.5
| 34
| 0.843994
| 0.743896
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 110
| 12
| 115
| 38
| 38.5
| 148.96875
| null | null | 1
| 136
| 7.389648
| 103
| 6
| 4,450
| 1
| null |
adl>=4 (>=5 if sur)
| 1.166748
| 114
| 1
|
53.47299
|
female
| 0
| 7
|
Lung Cancer
|
Cancer
| 2
| 16
|
>$50k
| 0
| null | 7,263.5156
| 4,564
| 7.5
|
white
| 17.097656
| 2
| 0.731934
| 0.461975
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 7
| 75
| 9.699219
| 70
| 24
| 37.79688
| 256.625
| null | null | 1.599854
| 147
| 7.459961
| 136
| 38
| 3,400
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 570
| 0
|
46.90198
|
male
| 1
| 21
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 11
|
under $11k
| 0
| 36,932
| 24,180.2188
| 23,668
| 19.333328
|
black
| 32.09375
| 63
| 0.533936
| 0.418945
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 21
| 72
| 9.798828
| 75
| 24
| 38.39844
| 385.6875
| null | 0.599976
| 1.299805
| 137
| 7.389648
| 111
| 12
| 1,120
| null | 7
|
<2 mo. follow-up
| 7
| 21
| 1
|
84.60199
|
female
| 0
| 14
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$25-$50k
| 0
| null | 17,063.7344
| 17,790
| 19
|
white
| 29.597656
| 53
| 0.60498
| 0.416992
| 1
| 0
| 0
|
no
| 0.5
| 0.45
|
no dnr
| 14
| 118
| 46.898438
| 96
| 26
| 36.5
| null | 3.199707
| 0.5
| 1.199951
| 129
| null | 80
| 16
| 2,870
| 0
| 0
| null | 0
| 199
| 1
|
64.48999
|
female
| 0
| 16
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 9
| null | 22,021.2812
| 22,701
| 22.666656
|
white
| 29
| 47
| 0.445984
| 0.244995
| 1
| 0
| 0
|
yes
| 0.5
| 0.5
|
no dnr
| 16
| 142
| 0.099991
| 160
| 28
| 34.59375
| 436
| 1.5
| 2
| 1.5
| 140
| 7.489258
| 333
| 34
| 1,345
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 569
| 0
|
54.81497
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| null | 6,166.4492
| 5,415
| 12
|
white
| 11.798828
| 11
| 0.814941
| 0.601929
| 1
| 0
| 0
|
metastatic
| 1
| 0.8
|
no dnr
| 5
| 62
| 5.199219
| 135
| 40
| 38.5
| 103.32812
| 1.5
| null | 1.699951
| 143
| 7.329102
| 160
| 26
| 1,955
| null | null | null | 1.861572
| 307
| 1
|
47.35397
|
female
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
| null | 0
| 54,872
| 32,157.9219
| 34,325
| 29
|
white
| 28.398438
| 50
| 0.771973
| 0.698975
| 4
| 1
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 21
| 60
| 12.199219
| 120
| 31
| 39.5
| 115
| 1.699951
| 1.099854
| 0.799927
| 145
| 7.519531
| 295
| 21
| 2,570
| null | 1
|
SIP>=30
| 1
| 271
| 1
|
38.70798
|
male
| 0
| 65
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
$25-$50k
| 9
| 262,777
| null | null | 26.75
|
white
| 29.199219
| 73
| 0.743896
| 0.662964
| 10
| 1
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 65
| 97
| 52.296875
| 104
| 24
| 38.5
| 223.78125
| 3.199707
| 4.699219
| 0.5
| 134
| 7.469727
| 212
| 13
| 3,050
| 1
| 2
|
SIP>=30
| 2
| 170
| 1
|
55.25299
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| null | 2,724.9902
| 3,168
| 10
|
white
| 18.199219
| 23
| 0.91394
| 0.85498
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 107
| 22.699219
| 175
| 11
| 37.89844
| 226.65625
| 2.299805
| 19.398438
| 6.699219
| 132
| 7.399414
| 167
| 99
| 105
| null | null | null | 2.062988
| 568
| 0
|
76.18896
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 6
|
under $11k
| 0
| null | 3,370.7441
| 3,742
| 7
|
black
| 19.398438
| 21
| 0.770996
| 0.634888
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 4
| 40
| 15.798828
| 135
| 18
| 38.39844
| 88.5625
| 2.199707
| 5.599609
| 1.899902
| 137
| 7.389648
| 175
| 15
| 3,735
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 568
| 0
|
58.97897
|
male
| 0
| 18
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 30,679
| 18,150.0938
| 15,333
| 8.666664
|
white
| 13.898438
| 9
| 0.862915
| 0.69397
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 18
| 55
| 1.299805
| 125
| 36
| 36.29688
| 200
| null | 1.299805
| 0.699951
| 145
| 7.359375
| 204
| 30
| 3,415
| null | 0
|
no(M2 and SIP pres)
| 0
| 492
| 1
|
71.16998
|
female
| 0
| 18
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 15
|
$25-$50k
| 9
| 32,147
| null | null | 19.666656
|
white
| 18.898438
| 33
| 0.664917
| 0.567993
| 3
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
dnr after sadm
| 3
| 138
| 22.5
| 110
| 40
| 36.39844
| 242.84375
| 2.5
| 0.399963
| 0.399963
| 123
| 7.429688
| 147
| 13
| 1,980
| null | 0
|
no(M2 and SIP pres)
| 0
| 440
| 1
|
76.02698
|
male
| 0
| 20
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 20
| null | 0
| 28,544
| 18,567.6094
| 21,607
| 13.666664
|
black
| 22.796875
| 41
| 0.642944
| 0.541992
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.4
|
dnr before sadm
| -1
| 123
| 12.199219
| 55
| 26
| 35.89844
| 212.5
| 3.899902
| 0.599976
| 3.5
| 143
| 7.369141
| 186
| 65
| 3,010
| 0
| 3
|
adl>=4 (>=5 if sur)
| 3
| 567
| 0
|
59.29099
|
female
| 1
| 46
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 3
|
under $11k
| 0
| 191,462
| null | null | 39
|
white
| 38.398438
| 69
| 0.540894
| 0.425964
| 1
| 1
| 0
|
no
| 0.7
| 0.7
|
dnr after sadm
| 43
| 73
| 6.699219
| 115
| 26
| 35.5
| 307.375
| 3.299805
| 0.599976
| 0.799927
| 134
| 7.459961
| 294
| 16
| 1,700
| null | 1
|
<2 mo. follow-up
| 1
| 46
| 1
|
71.47998
|
male
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| null | 12,923.5781
| 11,901
| 23
|
white
| 20.699219
| 27
| 0.744995
| 0.482971
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 10
| 105
| 2.399902
| 97
| 18
| 38.09375
| 400
| null | null | 0.899902
| 135
| 7.5
| 103
| 9
| null | null | 2
|
no(M2 and SIP pres)
| 2
| 565
| 0
|
69.59094
|
male
| 0
| 49
|
Coma
|
Coma
| 0
| null | null | 44
| 97,424
| null | null | 27
|
black
| 21.597656
| 19
| 0.48999
| 0.417969
| 2
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 49
| 50
| 16.5
| 105
| 22
| 38.59375
| 224
| null | null | 4
| 129
| 7.429688
| 116
| 76
| 370
| null | 0
|
SIP>=30
| 0
| 565
| 0
|
64.93396
|
female
| 0
| 9
|
Colon Cancer
|
Cancer
| 1
| 28
|
>$50k
| 0
| null | 11,891.6328
| 10,836
| 21
|
white
| 18.898438
| 15
| 0.789917
| 0.557983
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 9
| 120
| 8
| 115
| 7
| 36.5
| 213.3125
| 2.399902
| 0.299988
| 0.599976
| 135
| 7.439453
| 252
| 15
| 3,820
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 565
| 0
|
39.52597
|
female
| 0
| 39
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
>$50k
| 0
| 128,410
| 76,735.625
| 81,132
| 34.75
|
white
| 31.398438
| 86
| 0.565918
| 0.454956
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 39
| 62
| 7
| 84
| 2
| 36.59375
| 240
| null | 3.699707
| 2.899902
| 131
| 7.329102
| 86
| 48
| 234
| null | 0
|
SIP>=30
| 0
| 119
| 1
|
72.64099
|
male
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 9
| null | 13,854.9609
| 13,977
| 21.5
|
white
| 32.296875
| 14
| 0.419983
| 0.116989
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 10
| 63
| 5.599609
| 64
| 20
| 36.5
| null | 3.799805
| 0.299988
| 11
| 140
| null | 112
| 11
| 3,285
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 389
| 1
|
80.008
|
male
| 0
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 18,096
| 11,917.1875
| 12,747
| 17
|
white
| 16.296875
| 32
| 0.85791
| 0.765991
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 4
| 68
| 20.097656
| 70
| 29
| 35.59375
| 394.25
| 2.699707
| 1.599854
| 2.399902
| 137
| 7.349609
| 212
| 49
| 790
| 7
| 6
|
SIP>=30
| 6
| 477
| 1
|
77.76294
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| null | 5,457.9023
| 5,890
| 11
|
white
| 25.597656
| 45
| 0.705933
| 0.544922
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 9
| 65
| 46.296875
| 80
| 32
| 38.29688
| 265
| 3.199707
| 0.699951
| 1.5
| 133
| 7.429688
| 95
| 24
| 1,680
| 0
| null | null | 0.494751
| 564
| 0
|
84.435
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
$11-$25k
| 44
| null | null | null | 31
|
white
| 42.898438
| 80
| 0.017998
| 0.004
| 60
| 0
| 1
|
no
| null | null |
dnr after sadm
| 4
| 73
| 7.399414
| 80
| 20
| 36.59375
| null | null | 0.599976
| 0.899902
| 140
| null | 92
| 14
| 2,080
| null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
79.71497
|
male
| 1
| 40
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 3
|
under $11k
| 0
| 153,976
| 88,431.3125
| 84,070
| 45.25
|
white
| 17.296875
| 32
| 0.817993
| 0.756958
| 5
| 1
| 0
|
no
| 0.8
| 0.6
|
dnr after sadm
| 35
| 98
| 16.199219
| 119
| 36
| 37.89844
| 280.9375
| 1.399902
| null | 1.299805
| 146
| 7.389648
| 84
| 30
| 1,042
| null | null |
<2 mo. follow-up
| 2.28418
| 40
| 1
|
28.142
|
male
| 0
| 152
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 0
| 660,091
| null | null | 55.75
|
other
| 44.59375
| 81
| 0.572998
| 0.461975
| 1
| 0
| 0
|
no
| 0.05
| 0.05
|
no dnr
| 152
| 133
| 19.296875
| 115
| 22
| 39
| 362.8125
| null | null | 1.199951
| 151
| 7.529297
| 134
| 24
| 2,232
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 562
| 0
|
66.70496
|
female
| 1
| 4
|
Coma
|
Coma
| 1
| 12
|
under $11k
| 100
| null | 8,884.0078
| 9,813
| 25
|
black
| 31.699219
| 53
| 0.044998
| 0.022999
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 2
| 132
| 11.699219
| 65
| 0
| 36.09375
| 400
| null | null | 6.099609
| 140
| 7.399414
| 90
| 75
| 1,000
| null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
44.85699
|
male
| 0
| 31
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 12
| null | 0
| 121,495
| 75,694.625
| 82,343
| 21.5
|
white
| 22.796875
| 28
| 0.794922
| 0.670898
| 5
| 0
| 0
|
no
| 0.5
| 0.45
|
no dnr
| 31
| 52
| 17.296875
| 55
| 18
| 35.79688
| 91.65625
| null | 1.299805
| 1.199951
| 134
| 7.279297
| 73
| 14
| 4,400
| null | 0
|
no(M2 and SIP pres)
| 0
| 561
| 0
|
81.24298
|
male
| 0
| 53
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
| null | 9
| 144,170
| 86,758.1875
| 87,433
| 30
|
white
| 21.296875
| 35
| 0.658936
| 0.560913
| 5
| 0
| 0
|
yes
| 0.1
| 0.05
|
no dnr
| 53
| 105
| 3.5
| 65
| 10
| 34.79688
| 253.3125
| 2.199707
| 0.599976
| 1.099854
| 140
| 7.40918
| 207
| 15
| null | null | 0
| null | 0
| 72
| 1
|
39.034
|
male
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 100
| null | 15,246.4141
| 16,569
| 29.5
|
black
| 28.898438
| 54
| 0.44397
| 0.324951
| 1
| 1
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 6
| 82
| 13.798828
| 75
| 20
| 36
| 167.34375
| null | null | 3.699707
| 142
| 7.429688
| 185
| 69
| 200
| null | null |
<2 mo. follow-up
| 3.508301
| 9
| 1
|
69.08997
|
male
| 1
| 15
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 3
|
under $11k
| 9
| 62,341
| 36,025.25
| 36,720
| 32.666657
|
black
| 15.699219
| 25
| 0.873901
| 0.790894
| 1
| 1
| 0
|
no
| 0.7
| 0.7
|
dnr after sadm
| 14
| 55
| 12.5
| 125
| 0
| 38.09375
| 340
| 2.099609
| 0.699951
| 0.899902
| 137
| 7.379883
| 154
| 11
| 3,330
| null | 0
|
<2 mo. follow-up
| 0
| 15
| 1
|
74.53296
|
female
| 1
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 8
|
under $11k
| 41
| 16,283
| 9,550.2188
| 10,372
| 43
|
white
| 52.695313
| 73
| 0.002
| 0
| 1
| 0
| 0
|
yes
| 0.05
| 0.02
|
dnr after sadm
| 2
| 105
| null | 70
| 8
| 36.09375
| 193.3125
| null | null | 1.199951
| 132
| 7.40918
| 228
| 31
| 2,390
| null | 0
|
<2 mo. follow-up
| 0
| 3
| 1
|
67.64398
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
$25-$50k
| 44
| null | 61,174.4688
| 67,226
| 51
|
white
| 49.09375
| 102
| 0.009998
| 0.002
| 18
| 0
| 0
|
no
| 0.1
| 0.05
|
dnr after sadm
| 5
| 43
| 29.199219
| 120
| 8
| 38.39844
| 202
| 2.399902
| 5.599609
| 6.799805
| 131
| 7.40918
| 166
| 96
| 890
| null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
63.46899
|
male
| 1
| 7
|
Lung Cancer
|
Cancer
| 3
| 6
|
under $11k
| 0
| null | 8,803.6562
| 9,150
| 12
|
white
| 24.296875
| 23
| 0.541992
| 0.218994
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 4
| 123
| 7.399414
| 74
| 24
| 36
| 300
| 3.899902
| 0.599976
| 1
| 145
| 7.40918
| 96
| 12
| 1,100
| null | null |
<2 mo. follow-up
| 2.740723
| 7
| 1
|
33.77399
|
male
| 0
| 23
|
Coma
|
Coma
| 1
| 14
|
$25-$50k
| 61
| 83,227
| 47,545.5938
| 48,881
| 36
|
white
| 21.296875
| 16
| 0.724976
| 0.674927
| 2
| 0
| 0
|
no
| 0.7
| 0.8
|
no dnr
| 23
| 82
| 16.5
| 115
| 34
| 35.69531
| 195
| null | 1.799805
| 2.199707
| 145
| 7.40918
| 119
| 29
| 1,535
| null | 4
| null | 4
| 560
| 0
|
71.258
|
male
| 1
| 5
|
Coma
|
Coma
| 2
| 11
|
$11-$25k
| 94
| null | 10,750.5703
| 9,085
| 37
|
black
| 15.298828
| 11
| 0.425964
| 0.35199
| 1
| 1
| 0
|
no
| 0.1
| 0.05
|
dnr after sadm
| 2
| 80
| 10.898438
| 112
| 20
| 34.5
| null | 3.299805
| 0.5
| 1
| 138
| null | 108
| 16
| null | null | null |
<2 mo. follow-up
| 2.354981
| 5
| 1
|
59.16998
|
female
| 1
| 3
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 44
| null | 17,679.9531
| 17,592
| 52
|
black
| 58.5
| 101
| 0
| 0
| 7
| 0
| 0
|
yes
| 0.5
| 0.2
|
dnr after sadm
| 3
| 77
| 7.699219
| 68
| 18
| 37.89844
| null | null | null | 0.699951
| 141
| null | 86
| 7
| 4,175
| null | null |
<2 mo. follow-up
| 2.060547
| 3
| 1
|
67.70197
|
female
| 1
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 8
|
under $11k
| 0
| 78,431
| 46,890.5938
| 50,243
| 28
|
black
| 23.097656
| 41
| 0.755981
| 0.678955
| 10
| 1
| 0
|
no
| 0.7
| 0.6
|
dnr after sadm
| 19
| 112
| 9.099609
| 105
| 30
| 35.89844
| 207.5
| 2.599609
| 0.5
| 1.199951
| 142
| 7.399414
| 145
| 45
| 2,755
| null | null |
<2 mo. follow-up
| 2.359863
| 23
| 1
|
22.40099
|
male
| 1
| 7
|
Coma
|
Coma
| 0
| 11
|
$11-$25k
| 100
| 28,376
| null | null | 21.5
|
black
| 20.398438
| 20
| 0.703979
| 0.650879
| 1
| 0
| 0
|
no
| 0.1
| 0.05
|
dnr after sadm
| 6
| 40
| 26.296875
| 65
| 20
| 34
| 118.5625
| null | 0.899902
| 3
| 134
| 7.419922
| 363
| 27
| 12
| null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
69.65094
|
female
| 0
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
under $11k
| 44
| 43,552
| 26,990.4688
| 30,490
| 15.75
|
white
| 40.296875
| 67
| 0.122986
| 0.054993
| 1
| 0
| 1
|
yes
| 0.75
| 0.65
|
no dnr
| 28
| 55
| 10.298828
| 160
| 10
| 38
| 217.125
| 2.599609
| 3.699707
| 6.799805
| 135
| 7.349609
| 66
| 60
| 25
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 265
| 1
|
54.853
|
female
| 1
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 14
|
$11-$25k
| 0
| 390,011
| 229,951.75
| 257,862
| 53.5
|
white
| 35.195313
| 69
| 0.573975
| 0.462952
| 7
| 1
| 0
|
no
| 0.75
| 0.7
|
dnr after sadm
| 33
| 57
| 11.5
| 125
| 6
| 35.69531
| 310
| 0.599976
| null | 0.799927
| 132
| 7.389648
| 78
| 13
| 1,005
| null | 2
|
<2 mo. follow-up
| 2
| 34
| 1
|
64.33398
|
male
| 0
| 15
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 28,800
| 18,037.4062
| 18,055
| 14.666664
|
white
| 16.398438
| 35
| 0.81897
| 0.705933
| 1
| 0
| 0
|
no
| 0.6
| 0.3
|
no dnr
| 15
| 116
| 7.699219
| 110
| 28
| 36.79688
| null | 0.899902
| 7.599609
| 0.899902
| 145
| null | 118
| 17
| null | null | 0
|
no(M2 and SIP pres)
| 0
| 555
| 0
|
73.40198
|
female
| 1
| 10
|
Coma
|
Coma
| 0
| null |
under $11k
| 61
| 37,878
| 22,510.1094
| 24,040
| 37.5
|
black
| 22.199219
| 23
| 0.371948
| 0.297974
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 8
| 58
| 7.699219
| 105
| 45
| 35.69531
| 87.14062
| 2
| 0.399963
| 0.399963
| 144
| 7.40918
| 142
| 18
| 1,320
| null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
47.543
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 16
| null | 0
| 9,912
| 4,916.1719
| 2,209
| 15
|
white
| 8.5
| 12
| 0.863892
| 0.696899
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 4
| 52
| 21.5
| 100
| 12
| 39
| 78.5625
| null | 4.199219
| 3.799805
| 136
| 7.369141
| 261
| 60
| 135
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 236
| 1
|
66.17896
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 3
| null | 0
| 3,540
| 2,554.6914
| 2,990
| 15
|
black
| 17.699219
| 14
| 0.880981
| 0.80188
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 5
| 72
| 14.298828
| 95
| 29
| 36.79688
| 98.32812
| null | null | 0.799927
| 142
| 7.459961
| 156
| 31
| 765
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 553
| 0
|
66.90497
|
male
| 0
| 14
|
Lung Cancer
|
Cancer
| 1
| 15
|
$25-$50k
| 0
| 20,427
| 13,461.5547
| 14,506
| 11
|
white
| 25.097656
| 16
| 0.507935
| 0.186981
| 1
| 0
| 0
|
metastatic
| 0.4
| 0.2
|
no dnr
| 14
| 75
| 10.398438
| 115
| 24
| 37.79688
| 106.65625
| null | null | 0.799927
| 134
| 7.419922
| 114
| 17
| 2,410
| 0
| null |
<2 mo. follow-up
| 0.494751
| 19
| 1
|
41.35199
|
male
| 0
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 157,301
| 87,189.4375
| 84,195
| 32.25
|
white
| 23.398438
| 44
| 0.85791
| 0.807983
| 4
| 0
| 0
|
no
| 0.1
| 0.1
|
no dnr
| 33
| 112
| 8.798828
| 106
| 20
| 36.79688
| 103.32812
| null | null | 2.399902
| 147
| 7.279297
| 158
| 31
| 2,115
| null | null |
adl>=4 (>=5 if sur)
| 1.996094
| 551
| 0
|
61.52798
|
female
| 1
| 41
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 41
| 227,499
| 130,203.062
| 126,559
| 47
|
white
| 31.898438
| 39
| 0.444946
| 0.325989
| 4
| 0
| 0
|
no
| 0.7
| 0.7
|
dnr after sadm
| 35
| 96
| 5.299805
| 104
| 30
| 39.29688
| 172.5
| null | 1.299805
| 0.599976
| 134
| 7.399414
| 82
| 11
| 3,910
| null | 1
|
<2 mo. follow-up
| 1
| 41
| 1
|
59.38898
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| 5,506
| 3,822.9062
| 4,354
| 8
|
hispanic
| 13.099609
| 5
| 0.870972
| 0.709961
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 6
| 127
| 10.798828
| 140
| 35
| 38.59375
| 172.5
| 2.5
| 0.399963
| 2.099609
| 147
| 7.40918
| 90
| 57
| 3,005
| 0
| 0
| null | 0
| 60
| 1
|
56.31198
|
male
| 0
| 15
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 12
|
>$50k
| 9
| 46,602
| 30,916
| 26,684
| 18
|
white
| 22.398438
| 28
| 0.747925
| 0.602905
| 1
| 0
| 0
|
no
| 0.85
| 0.75
|
no dnr
| 15
| 76
| 16.296875
| 100
| 24
| 37.5
| null | 1.899902
| 4.599609
| 1.299805
| 139
| null | 75
| 12
| 980
| null | 0
|
<2 mo. follow-up
| 0
| 25
| 1
|
51.63599
|
female
| 0
| 77
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 456,885
| 282,560
| 278,900
| 32.75
|
black
| 28.398438
| 48
| 0.701904
| 0.612915
| 84
| 0
| 0
|
no
| 0.65
| 0.5
|
no dnr
| 77
| 80
| 5.099609
| 72
| 24
| 36.59375
| null | 3.399902
| 0.5
| 0.5
| 139
| null | 132
| 1.899902
| 2,650
| null | 0
|
no(M2 and SIP pres)
| 0
| 230
| 1
|
80.86499
|
female
| 1
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
under $11k
| 0
| 174,811
| 98,899.875
| 99,562
| 48.666657
|
black
| 31.5
| 51
| 0.48999
| 0.371948
| 10
| 0
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 17
| 50
| 23.898438
| 78
| 12
| 34.79688
| 383.3125
| 3.199707
| 0.399963
| 5.599609
| 140
| 7.469727
| 129
| 101
| 0
| null | 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
62.52197
|
male
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
>$50k
| null | null | null | null | null |
white
| null | null | null | null | 1
| 1
| 0
|
no
| null | null | null | null | 55
| 13.099609
| 110
| 25
| 35.89844
| null | null | null | 1.799805
| 133
| null | 259
| 60
| 3,170
| null | 0
|
<2 mo. follow-up
| 0
| 3
| 1
|
52.68399
|
male
| 1
| 31
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
|
>$50k
| 0
| 367,304
| null | null | 63
|
white
| 36.09375
| 77
| 0.636963
| 0.534912
| 1
| 0
| 0
|
no
| 0.4
| 0.4
|
no dnr
| 31
| 72
| 32.09375
| 115
| 25
| 35.89844
| 166.65625
| 2.899902
| 1.099854
| 0.799927
| 143
| 7.429688
| 221
| 38
| 2,530
| null | 0
|
<2 mo. follow-up
| 0
| 31
| 1
|
65.01599
|
female
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 9
| 33,672
| 19,349.9219
| 22,102
| 27
|
black
| 19.5
| 37
| 0.852905
| 0.756958
| 1
| 1
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 13
| 79
| 11.099609
| 86
| 20
| 37.39844
| null | 3.799805
| 0.799927
| 0.799927
| 137
| null | 109
| 9
| null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 546
| 0
|
40.00299
|
male
| 1
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 81,236
| null | null | 30.666656
|
black
| 35.695313
| 76
| 0.650879
| 0.55188
| 6
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 14
| 55
| 13.298828
| 75
| 26
| 36.39844
| 110.20312
| 1.699951
| null | 1.399902
| 140
| 7.319336
| 266
| 26
| 3,030
| null | 6
|
<2 mo. follow-up
| 6
| 14
| 1
|
43.168
|
male
| 0
| 54
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 104,206
| 63,689.6875
| 63,891
| 18
|
white
| 24.699219
| 32
| 0.861938
| 0.813965
| 1
| 0
| 0
|
no
| 0.85
| 0.85
|
no dnr
| 54
| 138
| 20.296875
| 155
| 36
| 38.69531
| 226.65625
| 2.699707
| 8.699219
| 1.199951
| 145
| 7.519531
| 226
| 25
| 3,645
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 547
| 0
|
70.28094
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 16
| null | 100
| 68,397
| 37,768.3125
| 41,464
| 38
|
white
| 26.597656
| 60
| 0.18399
| 0.095993
| 15
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 3
| 83
| 12.398438
| 72
| 20
| 36
| 254.53125
| null | 0.899902
| 1.5
| 137
| 7.379883
| 251
| 37
| null | null | 7
|
<2 mo. follow-up
| 7
| 4
| 1
|
63.14899
|
female
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 9,809
| 5,832.0078
| 5,343
| 13
|
black
| 25.296875
| 21
| 0.514893
| 0.192993
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.3
|
no dnr
| 7
| 86
| 13.599609
| 80
| 18
| 36.29688
| 171.40625
| null | 0.699951
| 1
| 135
| 7.439453
| 144
| 19
| null | 4
| 3
|
<2 mo. follow-up
| 3
| 54
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.